Header graphic for print
FDA Life News and Trends Impacting the FDA and Life Science Industry

Category Archives: Meetings

Subscribe to Meetings RSS Feed

Susan Winckler Featured Keynote Speaker This Week at 8th Annual Pharmaceutical and Medical Device Conference in Chicago on November 10

Posted in Advertising and Promotion, Animal Drugs, Antitrust, Biological Products, Clinical Studies, Drugs, Emerging Growth, Enforcement, European Union, FDA Organization, Healthcare, Intellectual Property, Legislation, Litigation, Medical Devices, Meetings, Patents, Regulation

159161119On November 10, 2016, McGuireWoods LLP and McGuireWoods Consulting (“McGuireWoods”) will be holding its 8th Annual Pharmaceutical and Medical Device Conference in Chicago.  Kicking off the Conference will be Keynote Speaker, Susan Winckler, the Chief Risk Management Officer for Continue Reading

McGuireWoods 8th Annual Pharmaceutical and Medical Device Conference in Chicago on November 10

Posted in Biological Products, Drugs, Medical Devices, Meetings

159161119Join us for an interactive conference addressing key legal and business matters focusing on innovation, investing, and regulatory issues in the pharmaceutical and medical device sectors.

Topics

  • Executive Roundtable – Life Sciences Industry Update
  • FDA Update – Recent Developments and
Continue Reading

FDAnews Expanded Access Briefing Features FDA, Industry, Patient Advocates, and Academia at McGuireWoods DC

Posted in Biological Products, Clinical Studies, Drugs, Medical Devices, Meetings, Regulation

McGuireWoods DCOn October 13, 2016, FDAnews is hosting its first in-person briefing at McGuireWoods LLP’s DC Office with the topic: “Expanded Access: FDA’s New Regulatory Process How Compassionate Use Fits into Proposed Reforms“.  The Briefing brings together key representatives … Continue Reading

IGBA and Medicines for Europe Hold Joint Annual Meeting in Dubrovnik, Croatia, in June 2016 – Part 2 of 2

Posted in Biosimilars, European Union, Generic Drugs, Meetings

croatiaThis is a continuation of coverage of the International Generic and Biosimilars Association (IGBA) (formerly known as the International Generic Pharmaceutical Alliance (IGPA)) and Medicines for Europe (formerly known as the European Generic and Biosimilars Association (EGA)) joint 19th IGBA Continue Reading

IGBA and Medicines for Europe Hold Joint Annual Meeting in Dubrovnik, Croatia, in June 2016 – Part 1 of 2

Posted in Biosimilars, European Union, Generic Drugs, Meetings

croatiaOn June 8-10, 2016, the International Generic and Biosimilars Association (IGBA) (formerly known as the International Generic Pharmaceutical Alliance (IGPA)) and Medicines for Europe (formerly known as the European Generic and Biosimilars Association (EGA)) held a joint 19th IGBA Continue Reading